Extract

The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and sirolimus is safe and feasible for patients with very high-risk solids tumors.

Inclusion criteria

• Refractory and/or Relapsed Metastatic Solid Tumors

Links

• nct
• ictrp